Defining alteration in bone marrow mesenchymal stem cells (MSC) from acute myeloid leukemia and exploring cultured MSC-conditioned media as a novel anti-leukemia therapy agent
Abstract Background Bone marrow-resident mesenchymal stem cells (BM-MSC) often play a role in acute myeloid leukemia (AML) progression and drug resistance by exerting immunomodulatory effects on cellular as well as soluble milieu. The current study aimed to understand the dynamic interplay between A...
保存先:
| 主要な著者: | , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer
2026-02-01
|
| シリーズ: | Cancer Immunology, Immunotherapy |
| 主題: | |
| オンライン・アクセス: | https://doi.org/10.1007/s00262-025-04262-2 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
